Modulating nitric oxide signaling in the CNS for Alzheimer's disease therapy.
about
CX3CL1/CX3CR1 in Alzheimer's Disease: A Target for NeuroprotectionTau Biology and Tau-Directed Therapies for Alzheimer's DiseaseDiscovery of novel PDE9 inhibitors capable of inhibiting Aβ aggregation as potential candidates for the treatment of Alzheimer's disease.Reduced cGMP levels in CSF of AD patients correlate with severity of dementia and current depression.Pharmacological approaches for Alzheimer's disease: neurotransmitter as drug targets.Emerging treatments for Alzheimer's disease for non-amyloid and non-tau targets.Selective inhibition of phosphodiesterases 4, 5 and 9 induces HSP20 phosphorylation and attenuates amyloid beta 1-42-mediated cytotoxicityProlonged acetylsalicylic-acid-supplementation-induced gastritis affects the chemical coding of the stomach innervating vagal efferent neurons in the porcine dorsal motor vagal nucleus (DMX).Modulation of inducible nitric oxide synthase (iNOS) expression and cardiovascular responses during static exercise following iNOS antagonism within the ventrolateral medulla.Decreased levels of guanosine 3', 5'-monophosphate (cGMP) in cerebrospinal fluid (CSF) are associated with cognitive decline and amyloid pathology in Alzheimer's disease.
P2860
Q26739374-C2760A95-556C-47DA-85AC-58EF02A8AD4FQ28071398-C1FBF962-16D4-4A47-9292-64A54D64CFAAQ36615734-D3425648-A758-4368-8BBD-8C583C5F32B6Q37689973-2C9C8FAC-587E-4118-8851-62FC8819BFA9Q38286222-AEB2589E-9D6B-43A6-9FBF-70650F03003EQ39296351-14F4C292-D679-4F45-AD25-BDAB0FDB980EQ41016698-432305EA-9C80-4523-835C-75FB96AB28E1Q42867139-CA58670B-54BB-41C4-98E0-83EF744C7218Q47811794-45B3951F-9DDF-44A1-9636-F91E81C20650Q48419390-4F6413C7-B1FE-4F0D-A0D5-E810FD9129BD
P2860
Modulating nitric oxide signaling in the CNS for Alzheimer's disease therapy.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Modulating nitric oxide signaling in the CNS for Alzheimer's disease therapy.
@en
type
label
Modulating nitric oxide signaling in the CNS for Alzheimer's disease therapy.
@en
prefLabel
Modulating nitric oxide signaling in the CNS for Alzheimer's disease therapy.
@en
P2860
P356
P1476
Modulating nitric oxide signaling in the CNS for Alzheimer's disease therapy.
@en
P2093
Qin Zhihui
P2860
P304
P356
10.4155/FMC.13.111
P577
2013-08-01T00:00:00Z